MIRA INFORM REPORT

 

 

Report Date :

18.10.2011

 

IDENTIFICATION DETAILS

 

Name :

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

 

 

Registered Office :

Laxmi Bhavan, Lakkadpitha Road, Vadodara – 390 001, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

12.06.1996

 

 

Com. Reg. No.:

04-29894

 

 

Capital Investment / Paid-up Capital :

Rs.32.319 millions

 

 

CIN No.:

[Company Identification No.]

U24232GJ1996PTC029894

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDT00509F

 

 

PAN No.:

[Permanent Account No.]

AABCT0623N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Phase Transfer Catalysts and Organic Quaternary Ammonium Compounds.

 

 

No. of Employees :

120 (Approximately)

  

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (49)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

 

 

  

Maximum Credit Limit :

USD 192100

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

 NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Chintan Nitinkumar Shah

Designation :

Director 

Contact No.:

91-9825153445

Date :

12.10.2011

 

 

LOCATIONS

 

Registered Office :

Laxmi Bhavan, Lakkadpitha Road, Vadodara – 390 001, Gujarat, India

Tel. No.:

91-265-2437093

Mobile No.:

91-9974249904 (Mr. Chetan Sheth), 91-9825445675 (Mr. Shekhar R Somani )

Fax No.:

91-265-2424495

E-Mail :

ajay@tatvachintan.com

info@tatvachintan.com

Website :

www.tatvachintan.com

Area :

1000 Sq. ft.  

Location :

Owned

 

 

Factory  :

502/17, G.I.D.C Estate, Ankleshwar – 393 002, Gujarat, India

Tel. No.:

91-2646-253593 / 238991

Fax No.:

91-2646-238992

E-Mail :

chintan@tatvachintan.com
shekhar@tatvachintan.com
info@tatvachintan.com

Area :

3000 Sq. ft.

Location :

Owned

 

 

DIRECTORS

 

AS ON 23.09.2010

 

Name :

Mr. Chintan Nitinkumar Shah

Designation :

Director

Address :

11-12, Sudhan Laxmi Jain Society, Subhanpura, Baroda – 390 023, Gujarat, India

Date of Birth/Age :

29.04.1973

Qualification :

B.E. (Computer Science)

Date of Appointment :

12.06.1996

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24232GJ1996PTC029894

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Director

12/06/1996

12/06/1996

-

Active

NO

2

U24231GJ2003PTC042991

CATALYST ORGANICS PRIVATE LIMITED

Director

01/10/2003

01/10/2003

-

Active

NO

 

 

Name :

Mr. Ajaykumar Mansukhlal Patel

Designation :

Director

Address :

9-645 Wadi Falia, Siddhmatani Sheri, Surat – 395 003, Gujarat, India

Date of Birth/Age :

27.02.1972

Qualification :

B.E. (Chemical)

Date of Appointment :

12.06.1996

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24232GJ1996PTC029894

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Director

12/06/1996

12/06/1996

-

Active

NO

2

U24231GJ2003PTC042991

CATALYST ORGANICS PRIVATE LIMITED

Director

01/10/2003

01/10/2003

-

Active

NO

 

 

Name :

Mr. Shekhar Rasiklal Somani

Designation :

Director

Address :

Mahavir Society, 51-52, 202 Mahavir Apartment, Zaveri Sadak, Navasari – 396 445, Gujarat, India

Date of Birth/Age :

11.01.1974

Qualification :

(B. Pharma) Young Entrepreneurs

Date of Appointment :

12.06.1996

 

 Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24232GJ1996PTC029894

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Director

12/06/1996

12/06/1996

-

Active

NO

2

U24231GJ2003PTC042991

CATALYST ORGANICS PRIVATE LIMITED

Director

01/10/2003

01/10/2003

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

M/S J J Gandhi and Company

Designation :

Company Secretary

Address :

231, Pheonix Complex, Besides Suraj Plaza, Sayajigunj, Vadodara – 390 005, Gujarat, India

Tel. No.:

91-265-2225022

Mobile No.:

91-9879020625/ 937420085

E-Mail :

jigandhi_cs@yahoo.co.in

jjgandhics@gmail.com

 

 Other Directorship:

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 23.09.2010

 

Names of Shareholders

No. of Shares

Chintan Shah

816014

Ajay Patel

727193

Shekhar Somani

833673

Rasiklal Somani

99660

Dashnaben Shah

147400

Priti Patel

257400

Kajal Somani

62260

Shital Shah

92400

Raxaben Patel

92400

Ranjanben Somani

52800

Sheetal Somani

4400

Samir Somani

24200

Chintan N Shah (HUF)

22000

Pravin Candra and Company, Mumbai

100

Total

3231900

 

 

Equity share breakup (percentage of total equity)

AS ON 23.09.2010

 

Category

Percentage

Directors or relatives of directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Phase Transfer Catalysts and Organic Quaternary Ammonium Compounds.

 

 

Products :

Product Description

ITC Code

Quarternary Compounds 

292390.00

 

·         Phase Transfer Catalysts

·         Glycol Diethers

·         Ionic Liquids

·         Ester Acetates

·         Bulk APls

 

 

Exports :

 

Products :

Chemical and Pharmaceutical Products

Countries :

·         Singapore

·         USA

·         Middle East

·         Europe

·         Australia

·         Bangladesh

·         Italy

·         South Africa

·         UAE etc.  

 

 

Imports :

 

Products :

Raw Materials

Countries :

·         China

·         Japan

·         USA

 

 

Terms :

 

Selling :

L/C, Cash, Credit (30 days,60 days) 

 

 

Purchasing :

L/C, Cash, Credit (30 days,60 days) 

 

 

PRODUCTION STATUS (AS ON 31.03.2010):-

 

Installed Capacity: 1500 MTPA 

 

Particulars

 

Unit

Actual Production

Quaternary Compounds

 

MT

748.602

Glymes

 

MT

4.664

Bulk Drugs

 

MT

229.593

Specialty  Chemicals

 

MT

26.165

Recovered Mix Solvent

 

mT

386.476

 

 

GENERAL INFORMATION

 

Customers :

OEM’s

 

 

No. of Employees :

120 (Approximately)

 

 

Bankers :

Bank of Baroda, Industrial Estate Branch, GIDC, Ankleshwar – 393 002, Gujarat, India

 

 

 Facilities :

Secured Loans 

31.03.2010

Rs. in millions

From Banks

 

Bank of Baroda, Ankelshwar

53.447

Term Loan I

3.405

Term Loan II

6.498

Term Loan III

17.655

Term Loan IV

0.510

Export Foreign Bill Purchase (Post-shipment)

4.287

Export Bill Purchased (Post-shipment)

2.207

Export Packing Credit (Pre-shipment)

13.500

Packing Credit Foreign Currency

3.586

Foreign Currency Bill Purchased

(Term Loan is secured against equitable mortgage of immovable properties and hypothecation of other fixed assets and cash credit is secured against hypothecation of current assets and personal guarantee of all directors)  

1.718

Motor Car Loan - I

0.304

Motor Car Loan - II

0.304

Motor Car Loan – III

(Secured against hypothecation of Motor Car Purchased  and personal guarantee of all directors)  

0.304

Total

107.725

 

Unsecured Loans 

31.03.2010

Rs. in millions

Deposits from Director    

3.586

Deposits from Shareholders

10.149

Total

13.735

  

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Pathak Anjaria and Company

Chartered Accountants

(Mr. Premal J Pathak, Partner, M. No. 42634)

Address :

2nd Floor, Leela Sadan, Vadodara – 390 001, Gujarat, India

Tel No.:

91-265-6538755

Mobile No.:

91-9824016006

Fax No.:

91-265-2420455 

Email :

pathakanjariaco@yahoo.com

 

 

Memberships :

Chemicals and Allied Products Export Promotion Council (CHEMEXCIL)

 

 

Sister Concern :

Tatva Chintan Laboratories 

Address: 502/17, GIDC, Ankleshwar – 393 002, Gujarat, India.

Year of Establishment : 1992

Activity : Manufacturers Sodium Citrate, Potassium Citrate, Sodium Acid, Citrate, Methyl Parabens, Propyl Paruben, Sodium Methyl Paraben, Sodium Propyl Paraben, etc.

 

  

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

4000000

Equity Shares

Rs.10/- each

Rs.30.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

3231900

Equity Shares

Rs.10/- each

Rs.32.319 millions

 

 

 

 

  

NoteS:

2119800 Equity Shares of Rs. 10/- each are allotted as fully paid – up bonus shares by way of capitalization of accumulated profits.

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

  

Particulars

 

 

 

31.03.2011

Sales Turnover (Approximately)

 

 

400.000

 

Expected Sales (2011-2012) : Rs.500.000 Millions

 

The above information has been parted by Mr. Chintan Nitinkumar Shah (Director)

 


ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

32.319

30.000

9.999

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

15.706

9.394

17.019

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

46.025

39.394

27.018

LOAN FUNDS

 

 

 

1] Secured Loans

107.726

60.303

37.220

2] Unsecured Loans

13.735

7.541

11.370

TOTAL BORROWING

121.461

67.844

48.590

DEFERRED TAX LIABILITIES

5.893

4.075

3.205

 

 

 

 

TOTAL

173.379

111.313

78.813

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

88.202

47.818

34.760

Capital work-in-progress

0.000

1.364

0.353

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

58.784
35.276
30.766

 

Sundry Debtors

55.048
57.363
36.593

 

Cash & Bank Balances

12.517
7.341
2.607

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

22.226
12.124
7.949

Total Current Assets

148.575
112.104
77.915

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

58.618
47.649
33.346

 

Other Current Liabilities

1.139
0.748
0.670

 

Provisions

1.865
1.768
0.211

Total Current Liabilities

61.622
50.165
34.227

Net Current Assets

86.953
61.939
43.688

 

 

 

 

MISCELLANEOUS EXPENSES

0.224

0.192

0.012

 

 

 

 

TOTAL

173.379

111.313

78.813

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

Income

282.797

239.379

166.397

 

 

Other Income

 

2.443

1.640

 

 

TOTAL                                     (A)

282.797

241.822

168.037

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Raw Material Consumed

255.258

147.058

103.489

 

 

Other Manufacturing Expenses

 

22.190

14.862

 

 

Remuneration to Personal

 

12.998

9.874

 

 

Excise Duty

 

20.437

18.337

 

 

Selling and Administrative Expenses

 

12.630

10.608

 

 

Loss of Fixed Assets

 

0.994

0.474

 

 

Increased/(Decreased) in Stock

 

1.633

(8.344)

 

 

TOTAL                                     (B)

255.927

217.940

149.300

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

26.870

23.882

18.737

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

10.309

5.978

5.521

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

16.561

17.904

13.216

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

3.848

2.059

1.728

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

12.713

15.845

11.488

 

 

 

 

 

Less

TAX                                                                  (I)

3.867

5.479

3.690

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

8.846

10.366

7.798

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

9.395

17.019

9.561

 

 

 

 

 

Add

PRIOR PERIOD ADJUSTMENTS

(0.669)

(0.035)

0.244

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Bonus Shares

0.000

16.200

0.000

 

 

Dividend

1.616

1.500

0.499

 

 

Income Tax on Dividend

0.249

0.254

0.085

 

BALANCE CARRIED TO THE B/S

15.707

9.396

17.019

 

 

 

 

 

 

Earnings Per Share (Rs.)

2.74

3.46

--

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

3.13
4.29
4.64

 

 

 
 
 

Net Profit Margin

(PBT/Sales)

(%)

4.49
6.62
6.90

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

5.37
9.82
10.20

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.28
0.40
0.43

 

 

 
 
 

Debt Equity Ratio

(Total Liability/Networth)

 

3.98
2.99
3.07

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

2.41
2.23
2.28

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

 Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

Yes

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter's background

 --

8) No. of employees

Yes

9) Name of person contacted

Yes

10) Designation of contact person

Yes

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

No

13) Reasons for variation <> 20%

No

14) Estimation for coming financial year

Yes

15) Capital in the business

No

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

Yes

20) Export / Import details (if applicable)

Yes

21) Market information

 --

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

 --

25) Conduct of the banking account

 --

26) Buyer visit details

 --

27) Financials, if provided

 No

28) Incorporation details, if applicable

 --

29) Last accounts filed at ROC

 --

30) Major Shareholders, if available

 --

 

Form 8:-

 

Name of the company

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Presented By

Bank of Baroda, Ankleshwar

Tatvachintan Pharma Chem Private Limited 

1) Date and description of instrument creating the change

Hypothecation Agreement dated 28.04.2005

2) Amount secured by the charge/amount owing on the securities of charge

Rs.22.950 millions

 

Particulars

(Rs. in millions)

Term Loan I

1.950

Term Loan II

6.000

Cash Credit – Hyp

(Stock and Book Debts)

 

12.000

Sub limit

 

PC cum FBP

(2.500)

Letter of Credit

3.000

 

 

Total

22.950

 

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Term Loan

Hypothecation of plant, machinery and equipments to the Hypothecation Agreement, both present and future, installed, situated and lying at Plot No. 502/17, GIDC, Ankleshwar.

 

For Other limits

Hypothecation of all kinds of goods viz. Raw materials, WIP< Finished Goods lying at Plot No. 502/17, GIDC, Ankleshwar and hypothecation of Book Debts and receivables and goods procured under L/C.

4) Gist of the terms and conditions and extent and operation of the charge.

Margin Stocks – 25%

Book Debts – 40%

Interest

Term Loan 2.75% OBPLR p.a. monthly rest

Cash Credit 2.00% OBPLR p.a. monthly rest

EPC – as per bank’s guidelines

Period Renewable after one year.

5) Name and Address and description of the person entitled to the charge.

Bank of Baroda

Industrial Estate Branch, GIDC, Ankleshwar

 

 

This form is for

Modification of charge

Corporate identity number of the company

U24232GJ1996PTC029894

Name of the company

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Laxmi Bhavan, Old Lakkadpitha Road, Vadodara – 390 001, Gujarat, India.

Type of charge

Immovable property

Particular of charge holder

Bank of Baroda

Industrial Estate Branch, GIDC, Ankleshwar – 393 002, Gujarat, India

Email: indank@bankofbaroda.com

Nature of description of the instrument creating or modifying the charge

Supplemental Memorandum of Entry 

Date of instrument Creating the charge

05.05.2008

Amount secured by the charge

Rs.74.893 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

Term Loan : BPLR p.a. with monthly rest

Cash Credit : 1% below BPLR

Packing Credit Limit : as per Bank guidelines

 

Terms of Repayment: Working Capital repayable on demand and Term Loans and Demand loan repayable as per schedule loan agreement.

 

Margin:

25% on all stocks

40% on all eligible book debts

25% Term Loan

25% on Inland/ Import Letter

 

Extent and Operation of the charge: First charge on the immovable properties of the company.

Short particulars of the property charged

Land and Building situated at GIDC Plot No. 502/8, Plot No. 502/18 Revenue survey No. 271/p within the village limit of Piraman Tal. Ankleshwar Dist. Bharuch

 

 

This form is for

Modification of charge

Charge identification number of the modified 

90110934

Corporate identity number of the company

U24232GJ1996PTC029894

Name of the company

TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Laxmi Bhavanlakkadpitha Road, Vadodara – 390001, Gujarat, India

 

Type of charge

Book Debts

Movable Property

Particular of charge holder

Bank of Baroda

Nature of description of the instrument creating or modifying the charge

Fourth Supplemental Composite Agreement of Hypothecation of Goods, Book Debts, Movable Machinery and Vehicles.

Date of instrument Creating the charge

12/06/2009

Amount secured by the charge

Rs.115.413 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Term Loan : BPLR p.a. with monthly rest

Cash Credit : 1% below BPLR

Packing Credit Limit : as per Bank guidelines

 

Terms of Repayment

Working capital repayable on demand and Term loan repayable as per schedule of loan agreement.

 

Margin

25% on all stocks

40% on all eligible book debts

25% Term Loan

25% on Inland / Import Letter

 

Extent and Operation of the charge

First charge on the movable properties of the company

Short particulars of the property charged

Borrower's stocks both present and future including raw materials, work in process, semi finished goods and finished goods such as chemicals, Pharmaceuticals Bulk Drugs, Intermediates, speciality fine chemicals, packing materials, stores etc. All present and future book debts, outstanding, money receivables, which is due and owing to the borrower in the course of its business. All tangible movable machineries and movable plants.

Date of latest modification prior to the present modification

05/05/2008

Particulars of the present modification 

The existing charge was enhanced from Rs.74.893 Millions to Rs.115.413 Millions so as it can secure the aggregate  additional finance facility of Rs.40.520 Millions.

 

Fixed Assets

·         Leasehold Land

·         Factory Building

·         Labour Quarters

·         Administration Building

·         Plant and Machinery

·         Gas Cylinders

·         Electrical Installations

·         Effluent Treat Plant

·         Two Wheelers

·         Furniture and Fixtures

·         Computer

·         R and D Equipment

·         Motor Car

·         Office Equipments

·         R and D Building

 

 

Web Details

 

Company Profile

Subject is an integrated growing specialty chemical and pharmaceutical company, promoted by three young and technocrats friends, founded in 1996 with the purpose of serving the community and aiming to become one of the fastest growing specialty chemical and pharmaceutical company in India.

Strong business relationships, commitment to outstanding quality and service make subject a preferred partner for its customers.

The company’s success is based on the expertise of its people, their ability to identify new customer needs at an early stage, and an enthusiasm to work together with customers to develop creative, efficient solutions

Company Philosophy

They believe the first responsibility is to the customers who use the products and services. In meeting their needs everything they do must be of high quality. They must constantly strive to reduce the costs in order to maintain reasonable prices. Customer orders must be serviced promptly and accurately. The suppliers and distributors must have an opportunity to make a fair profit.


They are responsible to the employees, the men and women who work with them throughout the world. Everyone must be considered as an individual. They must respect their dignity and recognize their merit. They must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions clean, orderly and safe. They must be mindful of ways to help the employees fulfill heir family responsibilities. Employees must fee! free to make suggestions and complaints, There must be equal opportunity for employment, development and advancement for those qualified. They must provide competent management, and their actions must be just and ethical.


They are responsible to the communities in which they live and work and to the world community as well. They must be good citizens - support good works and charities and bear the fair share of taxes. They must encourage civil improvements and better health and education. They must maintain in good order the property they are privileged to use, protecting the environment and natural resources. 

 

Chemical Inventor

 

In order to become a “CHEMICAL INVENTOR” that expands operations on a global scale, Subject has pursued the unlimited potential of chemistry and continued to raise challenges since its inception.


Subject is characterized by a flexible and advanced production system and fast, reliable deliveries. There is a strong emphasis on quality assurance to meet customers' demands for products of a uniform quality.


Subject is working on research and development based on the superior knowledge and advanced technical capabilities adapted to diverse market needs. Further they are creating new values in chemistry with drive and passion, in consideration of the global environment.

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.48.89

UK Pound

1

Rs.77.31

Euro

1

Rs.67.78

 

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

Yes

--LITIGATION

YES/NO

No

--OTHER ADVERSE INFORMATION

YES/NO

No

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

No

--EXPORT ACTIVITIES

YES/NO

Yes

--AFFILIATION

YES/NO

No

--LISTED

YES/NO

No

--OTHER MERIT FACTORS

YES/NO

Yes

TOTAL

 

49

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

>86

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

71-85

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

56-70

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

41-55

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

26-40

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

11-25

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

<10

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.